π₯π BizChicken ππ₯
Companies Similar to Ardelyx, Inc.
Sign Up Today!
Sign up for BizChicken and discover more about the corporations around you.
Aytu BioPharma, Inc.
Adzenys XR-ODT
Aytu Biopharma, Inc. is a specialty pharmaceutical company focused on developing and commercializing novel therapeutics and consumer healthcare products in the United States and internationally. They offer products for the treatment of ADHD, allergies, fluoride deficiency, cough, and insomnia.
Symbol: AYTU
Recent Price: $1.61
Industry: Drug Manufacturers - Specialty & Generic
CEO: Mr. Joshua R. Disbrow
Sector: Healthcare
Employees: 102
Address: 373 Inverness Parkway, Englewood, CO 80112
Phone: 720 437 6580
Last updated: 2024-12-31
Allarity Therapeutics, Inc.
Stenoparib, Dovitinib, IXEMPRA, Li Pla Cis, 2X-111
Allarity Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing oncology therapeutics using companion diagnostics and drug response predictor technology.
Careers | Careers | Careers | About | About | About | About | About | About | About | About | Contact | Contact | Contact | Careers | About | About | About | About | About | About | About | About
Symbol: ALLR
Recent Price: $1.12
Industry: Biotechnology
CEO: Mr. Thomas H. Jensen
Sector: Healthcare
Employees: 5
Address: 210 Broadway, Cambridge, MA 02139
Phone: 401 426 4664
Last updated: 2024-12-31
Amgen Inc.
Enbrel, Neulasta, Prolia, Xgeva, Otezla, Aranesp, KYPROLIS, Repatha, Nplate, Vectibix, MVASI, Parsabiv, EPOGEN, KANJINTI, BLINCYTO, Aimovig
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide, focusing on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience.
Jobs | About | About | History | Vision/Values | Leadership | Awards | About | ESG | About | About | About | Contact | About | DEI | About | About | About | About | About | About | About | About | Jobs | Jobs | Jobs | Careers | Careers | Jobs | Careers | Careers | Careers | Careers | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Careers | Careers | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Careers | Careers | Careers | Careers | Benefits | Careers | Locations | Events | Jobs | Careers | Careers | Careers | Site Map | Management | Careers | About | About | About | About | About | About | About | Jobs | Jobs | Jobs | Jobs
Symbol: AMGN
Recent Price: $259.30
Industry: Drug Manufacturers - General
CEO: Mr. Robert A. Bradway
Sector: Healthcare
Employees: 26700
Address: One Amgen Center Drive, Thousand Oaks, CA 91320-1799
Phone: 805 447 1000
Leadership
- Robert A. Bradway, Chairman and Chief Executive Officer
- James Bradner, Executive Vice President, Research and Development, and Chief Scientific Officer
- Sean Bruich, Senior Vice President Artificial Intelligence and Data
- Paul Burton, Senior Vice President and Chief Medical Officer
- Raymond Deshaies, Senior Vice President, Global Research
- Jackie Elbonne, Senior Vice President, Quality and Chief Quality Officer
- Murdo Gordon, Executive Vice President, Global Commercial Operations
- Jonathan Graham, Executive Vice President and General Counsel and Secretary
- Peter Griffith, Executive Vice President and Chief Financial Officer
- Nancy Grygiel, Senior Vice President, Worldwide Compliance & Business Ethics and Chief Compliance Officer
- Narimon Honarpour, Senior Vice President, Global Development
- Vikram Karnani, Executive Vice President, and President, Global Commercial Operations and Medical Affairs (Rare Disease)
- My Linh Kha, Senior Vice President and General Manager, Japan Asia-Pacific
- Rachna Khosla, Senior Vice President, Business Development
- Gilles Marrache, Senior Vice President, Regional General Manager
- Derek Miller, Senior Vice President, Human Resources
- Jerry Murry, Senior Vice President, Process Development
- Kave Niksefat, Senior Vice President, Global Marketing and Access
- Arleen Paulino, Senior Vice President, Manufacturing
- Annalisa Pizzarello, Senior Vice President, Results Delivery Office
- Greg Portner, Senior Vice President, Global Government Affairs and Policy
- Anton Rabushka, Senior Vice President, Finance
- Emily Razaqi, Senior Vice President, Obesity and Related Conditions
- David M. Reese, Executive Vice President and Chief Technology Officer
- Esteban Santos, Executive Vice President, Operations
- Darryl Sleep, Senior Vice President, Global Medical
- Jean-Charles Soria, Senior Vice President, Research and Development
- Susan Sweeney, Executive Vice President, Obesity and Related Conditions
- Mark J. Taisey, Senior Vice President, Global Regulatory Affairs and Strategy
- Susie Tappouni, Head of Corporate Affairs
- Ian Thompson, Senior Vice President, U.S. Business Operations
- Brenda Torres, Senior Vice President, Global Supply Chain
- Alper Γreten, Vice President, Commercialization and Program Management
- Wanda M. Austin, Retired President and Chief Executive Officer, The Aerospace Corporation
- Michael V. Drake, President, University of California
- Brian J. Druker, Physician-Scientist and Professor of Medicine, Oregon Health & Science University (OHSU), Director of the OHSU Knight Cancer Institute and JELD-WEN Chair of Leukemia Research, and Associate Dean for Oncology, OHSU School of Medicine
- Robert A. Eckert, Lead Independent Director, Chairman Emeritus, Mattel, Inc.
- Greg C. Garland, Former Executive Chairman and Former Chairman and Chief Executive Officer, Phillips 66
- Charles M. Holley, Jr., Former Executive Vice President and Chief Financial Officer of Wal-Mart Stores, Inc.
- S. Omar Ishrak, Former Executive Chairman and Chairman of the Board of Directors, Medtronic plc
- Tyler Jacks, David H. Koch Professor of Biology, Massachusetts Institute of Technology and Founding Director of the David H. Koch Institute for Integrative Cancer Research
- Mary E. Klotman, Executive Vice President for Health Affairs of Duke University, Dean of the Duke University School of Medicine, and Chief Academic Officer of Duke Health
- Ellen J. Kullman, Executive Chair of the Board and Former President and Chief Executive Officer of Carbon, Inc.
- Amy E. Miles, Former Chair of the Board and Chief Executive Officer, Regal Entertainment Group, Inc.
Last updated: 2024-12-31
Omeros Corporation
Narsoplimab
Omeros Corporation is a commercial-stage biopharmaceutical company that focuses on discovering, developing, and commercializing therapeutics for inflammation, immune-related cancers, and addictive disorders.
Symbol: OMER
Recent Price: $9.74
Industry: Biotechnology
CEO: Dr. Gregory A. Demopulos M.D.
Sector: Healthcare
Employees: 198
Address: The Omeros Building, Seattle, WA 98119
Phone: 206 676 5000
Last updated: 2024-12-31
Syndax Pharmaceuticals, Inc.
SNDX-5613, SNDX-6352 (axatilimab), Entinostat
Syndax Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on developing therapies for cancer treatment, including innovative candidates like SNDX-5613 and SNDX-6352. It collaborates with notable institutions like the National Cancer Institute and has a license agreement with Kyowa Hakko Kirin Co., Ltd.
Symbol: SNDX
Recent Price: $12.52
Industry: Biotechnology
CEO: Mr. Michael A. Metzger M.B.A.
Sector: Healthcare
Employees: 184
Address: 35 Gatehouse Drive, Waltham, MA 02451
Phone: 781 419 1400
Last updated: 2024-12-31
Tenax Therapeutics, Inc.
TNX-103, TNX-102 (levosimendan), TNX-201 (imatinib)
Tenax Therapeutics, Inc. is a specialty pharmaceutical company that focuses on identifying, developing, and commercializing products for cardiovascular and pulmonary diseases. The company is involved in developing medications such as TNX-103 and TNX-102 (levosimendan) for pulmonary hypertension and heart failure, and TNX-201 (imatinib) for pulmonary arterial hypertension.
Symbol: TENX
Recent Price: $6.55
Industry: Biotechnology
CEO: Mr. Christopher T. Giordano
Sector: Healthcare
Employees: 5
Address: ONE Copley Parkway, Morrisville, NC 27560
Phone: 919 855 2100
Last updated: 2024-12-31
Adial Pharmaceuticals, Inc.
AD04
Adial Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on developing therapeutics for addiction and related disorders. Its lead product, AD04, is in Phase III clinical trial for alcohol use disorder treatment.
Symbol: ADIL
Recent Price: $1.03
Industry: Biotechnology
CEO: Mr. Cary John Claiborne MBA
Sector: Healthcare
Employees: 4
Address: 1180 Seminole Trail, Charlottesville, VA 22901
Phone: 434 422 9800
Last updated: 2024-12-31
Akebia Therapeutics, Inc.
Vadadustat
Akebia Therapeutics, Inc. is a biopharmaceutical company focused on developing and commercializing therapeutics for kidney disease patients, with a lead product vadadustat for treating anemia due to chronic kidney disease.
Symbol: AKBA
Recent Price: $1.85
Industry: Biotechnology
CEO: Mr. John P. Butler MBA
Sector: Healthcare
Employees: 167
Address: 245 First Street, Cambridge, MA 02142
Phone: 617 871 2098
Last updated: 2024-12-31
Amylyx Pharmaceuticals, Inc.
AMX0035
Amylyx Pharmaceuticals is a clinical-stage biopharmaceutical company focused on developing therapeutics for amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases. Their leading product, AMX0035, is aimed at ALS treatment.
About | Leadership | Directors | Contact | Careers | About | About | About | About | About | About | About | About | News | About
Symbol: AMLX
Recent Price: $3.84
Industry: Biotechnology
CEO: Mr. Joshua B. Cohen
Sector: Healthcare
Employees: 384
Address: 43 Thorndike Street, Cambridge, MA 02141
Phone: 617 682 0917
Leadership
- Linda A. Arsenault, Chief Human Resources Officer
- Camille L. Bedrosian, MD, Chief Medical Officer
- Josh Cohen, Co-CEO & Co-Founder
- James M. Frates, Chief Financial Officer
- Tom Holmes, Chief Technical Operations Officer
- Justin Klee, Co-CEO & Co-Founder
- Gina M. Mazzariello, Chief Legal Officer & General Counsel
- Rudolph Tanzi, PhD, Founding Chair of the Amylyx SAB
- Wally Gilbert, Special Advisor
- Kari Firestone, Director
- Paul Fonteyne, Director
- George Milne, Chairman
- Daphne Quimi, Director
- Bernhardt G. Zeiher, MD, FACP, FCCP, Director
Last updated: 2024-12-31
Ardelyx, Inc.
tenapanor
Ardelyx, Inc. is a biopharmaceutical company focused on discovering, developing, and commercializing medicines for gastrointestinal and cardiorenal therapeutic areas, including treatments for irritable bowel syndrome with constipation and hyperphosphatemia.
About | Vision/Values | Leadership | About | About | About | About | Contact | About | About | About
Symbol: ARDX
Recent Price: $5.25
Industry: Biotechnology
CEO: Mr. Michael G. Raab
Sector: Healthcare
Employees: 267
Address: 400 Fifth Avenue, Waltham, MA 02451
Phone: 510 745 1700
Leadership
- Justin Renz, Chief Financial & Operations Officer
- Eric Foster, Chief Commercial Officer
- Elizabeth Grammer, Esq., Chief Legal & Administrative Officer
- Laura Williams, MD MPH, Chief Medical Officer
- Robert Blanks, MS RAC, Chief Regulatory Affairs & Quality Assurance Officer
- David Rosenbaum, PhD, Chief Development Officer
- Mike Kelliher, Executive Vice President, Corporate Development and Strategy
- Charon Spencer, Chief Human Resources Officer
- David Mott, Chairman
- Robert Bazemore, Director
- William A. Bertrand, Jr., JD, Director
- Muna Bhanji, R.Ph, Director
- Onaiza Cadoret-Manier, Director
- Mike Raab, Director
- Richard Rodgers, Director
Last updated: 2024-12-31
Axsome Therapeutics, Inc.
AXS-05, AXS-07, AXS-12, AXS-14
Axsome Therapeutics, Inc. is a biopharmaceutical company focused on developing novel therapies for central nervous system disorders such as major depressive disorder, migraine, narcolepsy, and fibromyalgia.
About | Leadership | Directors | About | About | About | About | About | About | Contact | Careers | Careers | About | About
Symbol: AXSM
Recent Price: $84.78
Industry: Biotechnology
CEO: Dr. Herriot Tabuteau M.D.
Sector: Healthcare
Employees: 589
Address: 22 Cortlandt Street, New York, NY 10007
Phone: 212 332 3241
Leadership
- Herriot Tabuteau, MD, CHIEF EXECUTIVE OFFICER
- Nick Pizzie, CPA, MBA, CHIEF FINANCIAL OFFICER
- Mark Jacobson, MA, CHIEF OPERATING OFFICER
- Hunter Murdock, Esq., GENERAL COUNSEL
- ari Maizel, Executive Vice President, Head of Commercial
- Mark Coleman, MD, DIRECTOR
- Roger Jeffs, PhD, DIRECTOR
- Susan Mahony, PhD, MBA, DIRECTOR
- Mark Saad, DIRECTOR
Last updated: 2024-12-31
BioCryst Pharmaceuticals, Inc.
ORLADEYO
Bio Cryst Pharmaceuticals, Inc. is a biotechnology company focused on discovering novel, oral, and small-molecule medicines, with marketed products including RAPIVAB and ORLADEYO, and a pipeline featuring BCX9930, BCX9250, and Galidesivir.
About | About | About | Contact | Careers | Careers | Safety | Jobs | Careers | About | About | About | About
Symbol: BCRX
Recent Price: $7.53
Industry: Biotechnology
CEO: Mr. Jon P. Stonehouse
Sector: Healthcare
Employees: 536
Address: 4505 Emperor Boulevard, Durham, NC 27703
Phone: 919 859 1302
Last updated: 2024-12-31
iTeos Therapeutics, Inc.
inupadenant, EOS-448
Iteos Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on the discovery and development of immuno-oncology therapeutics. Their product pipeline includes inupadenant and EOS-448, which are in various phases of clinical trials.
About | Leadership | Directors | About | About | About | About | Contact | Careers | About | About | About | About | About | About
Symbol: ITOS
Recent Price: $7.29
Industry: Biotechnology
CEO: Dr. Michel Detheux Ph.D.
Sector: Healthcare
Employees: 157
Address: 321 Arsenal Street, Cambridge, MA 02472-5710
Phone: 339 217 0161
Leadership
- Michel DETHEUX, President, Chief Executive Officer
- Matt CALL, Chief Operating Officer
- Matthew GALL, Chief Financial Officer
- Yvonne MCGRATH, Chief Scientific Officer
- David Feltquate, Chief Medical Officer
- Philippe BRANTEGEM, Executive Vice President of Human Resources
- Adi OSOVSKY, Executive Vice President of Legal
- David HALLAL, Chair of the Board
- Aaron DAVIS,
- Jill DESIMONE,
- David LEE,
- Tim VAN HAUWERMEIREN,
- Tony HO,
- Robert IANNONE,
- Ann RHOADS,
Last updated: 2024-12-31
Ligand Pharmaceuticals Incorporated
Kyprolis, Evomela, Veklury, Teriparatide, Vaxneuvance, Pneumosil, Rylaze, Nexterone, Zulresso, Noxafil-IV
Ligand Pharmaceuticals Incorporated is a biopharmaceutical company focused on developing or acquiring technologies to aid pharmaceutical companies in discovering and developing medicines. The company's commercial programs include treatments for multiple myeloma, COVID-19, osteoporosis, invasive diseases, childhood pneumonia, and acute lymphoblastic leukemia.
Symbol: LGND
Recent Price: $105.76
Industry: Biotechnology
CEO: Mr. Todd C. Davis Ph.D.
Sector: Healthcare
Employees: 58
Address: 5980 Horton Street, EmeryVille, CA 94608
Phone: 858 550 7500
Last updated: 2024-12-31
Nurix Therapeutics, Inc.
NX-2127, NX-5948, NX-1607, NX-0255
Nurix Therapeutics, Inc. is a biopharmaceutical company that focuses on developing small molecule therapies for cancer and immune disorders, with products targeting BTK and CBL-B proteins. The company collaborates with Gilead Sciences and Sanofi.
Symbol: NRIX
Recent Price: $18.64
Industry: Biotechnology
CEO: Dr. Arthur T. Sands M.D., Ph.D.
Sector: Healthcare
Employees: 284
Address: 1700 Owens Street, San Francisco, CA 94158
Phone: 415 660 5320
Last updated: 2024-12-31
Acelyrin, Inc.
izokibep
Acelyrin, Inc. is a clinical biopharma company focused on developing and commercializing transformative medicines, with key products targeting conditions like Hidradenitis Suppurativa and Psoriatic Arthritis.
Symbol: SLRN
Recent Price: $3.08
Industry: Biotechnology
CEO: Ms. Mina Kim
Sector: Healthcare
Employees: 93
Address: 4149 Liberty Canyon Road, Agoura Hills, CA 91301
Phone: 805-730-0360
Last updated: 2024-12-31
Trevena, Inc.
OLINVYK (Oliceridine) injection
Trevena, Inc. is a biopharmaceutical company focused on developing and commercializing novel medicines for central nervous system disorders, with products like OLINVYK and collaborations such as with Imperial College London.
Symbol: TRVN
Recent Price: $1.50
Industry: Biotechnology
CEO: Ms. Carrie L. Bourdow
Sector: Healthcare
Employees: 23
Address: 955 Chesterbrook Boulevard, Chesterbrook, PA 19087
Phone: 610 354 8840
Leadership
- Carrie L. Bourdow, President and Chief Executive Officer
- Mark A. Demitrack, MD, Senior Vice President, Chief Medical Officer
- Barry Shin, Executive Vice President, Chief Operating Officer and Chief Financial Officer
- Robert T. Yoder, Senior Vice President, Chief Business Officer, Head of Commercial Operations & Chief Compliance Officer
- Scott Braunstein, M.D., Lead Independent Director
- Dr. Mark Corrigan, Acting CEO
- Marvin H. Johnson, Jr., Board Member
- Jake R. Nunn, Board Member
- Anne M. Phillips, M.D., Board Member
- Barbara Yanni, Board Member
Last updated: 2024-12-31
Y-mAbs Therapeutics, Inc.
DANYELZA
Y-m Abs Therapeutics, Inc., is a commercial-stage biopharmaceutical company focused on developing and commercializing novel antibody-based therapeutic products for cancer treatment in the United States.
Symbol: YMAB
Recent Price: $7.76
Industry: Biotechnology
CEO: Mr. Michael Rossi
Sector: Healthcare
Employees: 100
Address: 230 Park Avenue, New York, NY 10169
Phone: 646 885 8505
Leadership
- Michael Rossi, President and Chief Executive Officer
- Thomas Gad, Founder, Vice Chairman of the Board of Directors, Chief Business Officer
- Torben Lund-Hansen, SVP, Chief Technical Officer
- Peter Pfreundschuh, Chief Financial Officer
- Vignesh Rajah, SVP, Chief Medical Officer
- Joris Wilms, SVP, Chief Operating Officer
- Sue Smith, SVP, Chief Commercial Officer
- Norman LaFrance, Chief Development Officer
- Johan Wedell-Wedellsborg, Chairman
- Ashutosh Tyagi, M.D.,
- James I. Healy, Chairman
- David N. Gill,
- Laura J. Hamill,
- Mary Tagliaferri, M.D.,
Last updated: 2024-12-31
Eagle Pharmaceuticals, Inc.
Ryanodex, Belrapzo, Bendeka, EP-4104, PEMFEXY, EA-114, Vasopressin
Eagle Pharmaceuticals, Inc. specializes in the development and commercialization of pharmaceutical products targeting diseases of the central nervous system, metabolic critical care, and oncology in the U.S. Notable products include Ryanodex for malignant hyperthermia, and oncology treatments Belrapzo and Bendeka.
Symbol: EGRX
Recent Price: $0.50
Industry: Drug Manufacturers - Specialty & Generic
CEO: Mr. Michael Graves
Sector: Healthcare
Employees: 134
Address: 50 Tice Boulevard, Woodcliff Lake, NJ 07677
Phone: 201 326 5300
Last updated: 2024-12-31
Terns Pharmaceuticals, Inc.
TERN-101, TERN-201, TERN-501, TERN-601
Terns Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on developing small-molecule therapies for non-alcoholic steatohepatitis (NASH) and obesity, incorporating products like TERN-101, TERN-201, TERN-501, and TERN-601.
About | Contact | Careers | Careers | Careers | About | About | Careers | Culture | About | Leadership | About
Symbol: TERN
Recent Price: $7.15
Industry: Biotechnology
CEO: Ms. Amy L. Burroughs M.B.A.
Sector: Healthcare
Employees: 66
Address: 1065 East Hillsdale Boulevard, Foster City, CA 94404
Phone: 650 525 5535
Last updated: 2024-11-08